請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64432
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 葉秀慧(Shiou-Hwei Yeh) | |
dc.contributor.author | Yi-Jin Wu | en |
dc.contributor.author | 吳宜瑾 | zh_TW |
dc.date.accessioned | 2021-06-16T17:46:51Z | - |
dc.date.available | 2017-09-19 | |
dc.date.copyright | 2012-09-19 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-08-14 | |
dc.identifier.citation | 1. Merican, I., et al., Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol, 2000. 15(12): p. 1356-61.
2. Bridges, J.F., et al., Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res, 2011. 11: p. 298. 3. de Villa, V. and C.M. Lo, Liver transplantation for hepatocellular carcinoma in Asia. Oncologist, 2007. 12(11): p. 1321-31. 4. Seeger, C. and W.S. Mason, Hepatitis B virus biology. Microbiol Mol Biol Rev, 2000. 64(1): p. 51-68. 5. Stevens, C.E., et al., Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA, 1985. 253(12): p. 1740-5. 6. Fung, J., et al., Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother, 2011. 66(12): p. 2715-25. 7. Yuen, M.F. and C.L. Lai, Treatment of chronic hepatitis B: Evolution over two decades. J Gastroenterol Hepatol, 2011. 26 Suppl 1: p. 138-43. 8. Kwon, H. and A.S. Lok, Hepatitis B therapy. Nat Rev Gastroenterol Hepatol, 2011. 8(5): p. 275-84. 9. Ganem, D., J.R. Pollack, and J. Tavis, Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis, 1994. 3(2-3): p. 85-93. 10. Locarnini, S., Molecular virology of hepatitis B virus. Seminars in Liver Disease, 2004. 24: p. 3-10. 11. Tiollais, P., P. Charnay, and G.N. Vyas, Biology of hepatitis B virus. Science, 1981. 213(4506): p. 406-11. 12. Klingmuller, U. and H. Schaller, Hepadnavirus Infection Requires Interaction between the Viral Pre-S Domain and a Specific Hepatocellular Receptor. Journal of Virology, 1993. 67(12): p. 7414-7422. 13. Ganem, D., Assembly of Hepadnaviral Virions and Subviral Particles. Current Topics in Microbiology and Immunology, 1991. 168: p. 61-83. 14. Takahashi, K., et al., Immunochemical structure of hepatitis B e antigen in the serum. J Immunol, 1983. 130(6): p. 2903-7. 15. Ganem, D. and A.M. Prince, Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med, 2004. 350(11): p. 1118-29. 16. Bartenschlager, R., M. Junkerniepmann, and H. Schaller, The P-Gene Product of Hepatitis-B Virus Is Required as a Structural Component for Genomic Rna Encapsidation. Journal of Virology, 1990. 64(11): p. 5324-5332. 17. Bartenschlager, R. and H. Schaller, Hepadnaviral Assembly Is Initiated by Polymerase Binding to the Encapsidation Signal in the Viral-Rna Genome. Embo Journal, 1992. 11(9): p. 3413-3420. 18. Chiang, P.W., et al., Characterization of a Cis Element Required for Packaging and Replication of the Human Hepatitis B-Virus. Virology, 1992. 186(2): p. 701-711. 19. Junkerniepmann, M., R. Bartenschlager, and H. Schaller, A Short Cis-Acting Sequence Is Required for Hepatitis-B Virus Pregenome Encapsidation and Sufficient for Packaging of Foreign Rna. Embo Journal, 1990. 9(10): p. 3389-3396. 20. Pollack, J.R. and D. Ganem, An Rna Stem-Loop Structure Directs Hepatitis-B Virus Genomic Rna Encapsidation. Journal of Virology, 1993. 67(6): p. 3254-3263. 21. Gerlich, W.H. and W.S. Robinson, Hepatitis-B Virus Contains Protein Attached to the 5' Terminus of Its Complete DNA Strand. Cell, 1980. 21(3): p. 801-809. 22. Wang, G.H. and C. Seeger, The Reverse-Transcriptase of Hepatitis-B Virus Acts as a Protein Primer for Viral-DNA Synthesis. Cell, 1992. 71(4): p. 663-670. 23. Seeger, C., D. Ganem, and H.E. Varmus, Biochemical and Genetic-Evidence for the Hepatitis-B Virus-Replication Strategy. Science, 1986. 232(4749): p. 477-484. 24. Will, H., et al., Replication Strategy of Human Hepatitis-B Virus. Journal of Virology, 1987. 61(3): p. 904-911. 25. Locarnini, S., Molecular virology of hepatitis B virus. Semin Liver Dis, 2004. 24 Suppl 1: p. 3-10. 26. Hirsch, R.C., et al., Polymerase Gene-Products of Hepatitis-B Viruses Are Required for Genomic Rna Packaging as Well as for Reverse Transcription. Nature, 1990. 344(6266): p. 552-555. 27. Gallina, A., et al., A Recombinant Hepatitis-B Core Antigen Polypeptide with the Protamine-Like Domain Deleted Self-Assembles into Capsid Particles but Fails to Bind Nucleic-Acids. Journal of Virology, 1989. 63(11): p. 4645-4652. 28. Cohen, B.J. and J.E. Richmond, Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature, 1982. 296(5858): p. 677-9. 29. Wingfield, P.T., et al., Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry, 1995. 34(15): p. 4919-32. 30. Beames, B. and R.E. Lanford, Carboxy-Terminal Truncations of the Hbv Core Protein Affect Capsid Formation and the Apparent Size of Encapsidated Hbv Rna. Virology, 1993. 194(2): p. 597-607. 31. Nassal, M., The Arginine-Rich Domain of the Hepatitis-B Virus Core Protein Is Required for Pregenome Encapsidation and Productive Viral Positive-Strand DNA-Synthesis but Not for Virus Assembly. Journal of Virology, 1992. 66(7): p. 4107-4116. 32. Zlotnick, A., et al., Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry, 1996. 35(23): p. 7412-7421. 33. Birnbaum, F. and M. Nassal, Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol, 1990. 64(7): p. 3319-30. 34. Gazina, E.V., et al., Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. Journal of Virology, 2000. 74(10): p. 4721-4728. 35. Kock, J., et al., Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA. Journal of Virology, 2004. 78(24): p. 13812-13818. 36. Le Pogam, S., et al., Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). Journal of Virology, 2005. 79(3): p. 1871-1887. 37. Bottcher, B., S.A. Wynne, and R.A. Crowther, Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature, 1997. 386(6620): p. 88-91. 38. Schadler, S. and E. Hildt, HBV life cycle: entry and morphogenesis. Viruses, 2009. 1(2): p. 185-209. 39. Dryden, K.A., et al., Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol Cell, 2006. 22(6): p. 843-50. 40. Kenney, J.M., et al., Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure, 1995. 3(10): p. 1009-19. 41. Liu, S., et al., Structural comparisons of hepatitis B core antigen particles with different C-terminal lengths. Virus Res, 2010. 149(2): p. 241-4. 42. Albin, C. and W.S. Robinson, Protein kinase activity in hepatitis B virus. J Virol, 1980. 34(1): p. 297-302. 43. Gerlich, W.H., et al., Specificity and localization of the hepatitis B virus-associated protein kinase. J Virol, 1982. 42(3): p. 761-6. 44. Perlman, D.H., et al., Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc Natl Acad Sci U S A, 2005. 102(25): p. 9020-5. 45. Gazina, E.V., et al., Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J Virol, 2000. 74(10): p. 4721-8. 46. Pugh, J., A. Zweidler, and J. Summers, Characterization of the major duck hepatitis B virus core particle protein. J Virol, 1989. 63(3): p. 1371-6. 47. Roossinck, M.J. and A. Siddiqui, In vivo phosphorylation and protein analysis of hepatitis B virus core antigen. J Virol, 1987. 61(4): p. 955-61. 48. Yeh, C.T. and J.H. Ou, Phosphorylation of hepatitis B virus precore and core proteins. J Virol, 1991. 65(5): p. 2327-31. 49. Nurse, P., Universal control mechanism regulating onset of M-phase. Nature, 1990. 344(6266): p. 503-8. 50. Welch, P.J. and J.Y. Wang, Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc Natl Acad Sci U S A, 1992. 89(7): p. 3093-7. 51. Daub, H., et al., Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. Journal of Virology, 2002. 76(16): p. 8124-8137. 52. Liao, W. and J.H. Ou, Phosphorylation and Nuclear-Localization of the Hepatitis-B Virus Core Protein - Significance of Serine in the 3 Repeated Sprrr Motifs. Journal of Virology, 1995. 69(2): p. 1025-1029. 53. Lan, Y.T., et al., Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology, 1999. 259(2): p. 342-8. 54. Lewellyn, E.B. and D.D. Loeb, Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically. PLoS One, 2011. 6(2): p. e17202. 55. Kann, M. and W.H. Gerlich, Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol, 1994. 68(12): p. 7993-8000. 56. Kann, M., et al., Characterization of the Endogenous Protein-Kinase Activity of the Hepatitis-B Virus. Archives of Virology, 1993: p. 53-62. 57. Liao, W. and J.H. Ou, Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J Virol, 1995. 69(2): p. 1025-9. 58. Benn, J. and R.J. Schneider, Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A, 1995. 92(24): p. 11215-9. 59. Kann, M., et al., Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol, 1999. 145(1): p. 45-55. 60. Kau, J.H. and L.P. Ting, Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase. J Virol, 1998. 72(5): p. 3796-803. 61. Wu, C.H., et al., Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J Biol Chem, 2009. 284(8): p. 5229-39. 62. Churchill, M.E. and M. Suzuki, 'SPKK' motifs prefer to bind to DNA at A/T-rich sites. Embo Journal, 1989. 8(13): p. 4189-95. 63. Hill, C.S., et al., Histone - DNA Interactions and Their Modulation by Phosphorylation of -Ser-Pro-X-Lys/Arg- Motifs. Embo Journal, 1991. 10(7): p. 1939-1948. 64. Churchill, M.E.A. and A.A. Travers, Protein Motifs That Recognize Structural Features of DNA. Trends in Biochemical Sciences, 1991. 16(3): p. 92-97. 65. Le Pogam, S., et al., Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). J Virol, 2005. 79(3): p. 1871-87. 66. Chua, P.K., et al., Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach. J Virol, 2010. 84(5): p. 2340-51. 67. Kau, J.H. and L.P. Ting, Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase. Journal of Virology, 1998. 72(5): p. 3796-3803. 68. Duclos-Vallee, J.C., et al., Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity. J Gen Virol, 1998. 79 ( Pt 7): p. 1665-70. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64432 | - |
dc.description.abstract | B型肝炎病毒(HBV)核殼蛋白(nucleocapsid protein)共183個胺基酸,其中1-149胺基酸為assembly domain,150-183胺基酸為nucleic acid-binding domain。多篇研究指出,核殼蛋白對於HBV在進行複製時扮演著重要的角色,藉由C端Serine位點(S155、S162、S170)磷酸化修飾的有無,可能影響複製過程中的包殼(Encapsidation)及反轉錄 (Reverse transcription)步驟之進行。由於先前的文獻都是利用點突變方式將Serine變成Alanine,導致特定位點無法進行磷酸化,以探討核殼蛋白之磷酸化修飾對HBV生活史之影響。然而突變成Alanine的核殼蛋白可能會造成結構改變,無法直接證明其C端特定Serine位點磷酸化修飾之重要性。我們因此提出利用製備可專一辨識核殼蛋白C端特定Serine位點Phosphorylated form之抗體,探討核殼蛋白C端Serine位點磷酸化修飾於生活史中不同階段之變化,並用於尋找細胞中負責此磷酸化修飾之磷酸酶(Kinase),以釐清及其對HBV生活史中Encapsidation和Reverse transcription之影響。
為此,我們針對HBV核殼蛋白C端特定Serine位點,利用Synthetic peptide共製備了四支抗體。Dot-blot結果指出P4-P抗體有可能辨認核殼蛋白未經磷酸化修飾的S162位點。進一步利用點突變HBc質體分析P4-P抗體所辨認的HBc之磷酸化修飾位點,將表現Wild type及針對C端特定Serine位點進行點突變之核殼蛋白表現質體送入細胞中,利用P4-P抗體進行Western blot分析,發現此抗體傾向辨認經CIP處理之核殼蛋白;且除S162A外,其S170A之點突變亦會造成其對核殼蛋白較高之辨識力。我們因此提出一假說,認為HBV核殼蛋白C端之磷酸化修飾,有可能影響其結構之改變,決定Arginine rich之序列與病毒RNA之結合。而P4-P抗體對S162A及S170A突變之較強訊號,反應出其可能辨識未經磷酸化修飾的核殼蛋白C端結構,而此結構會降低核殼蛋白進行RNA Encapsidation之能力。 利用P4-P抗體的特性,我們接著利用kinase inhibitor處理細胞之策略,指出PKA有可能為參與調控核殼蛋白C端結構之磷酸酶。進一步針對核殼蛋白C端序列中可能為PKA標的之S168及S176位點,分別進行點突變,發現PKA有可能經由其對S168位點之磷酸化修飾,影響核殼蛋白C端結構。 本研究藉由一傾向辨認去磷酸化核殼蛋白之抗體之分析結果,提出HBV核殼蛋C端之磷酸化修飾有可能透過改變其結構,而影響其對病毒RNA進行Encapsidation能力之假說,並指出PKA有可能為細胞中調控此結構之磷酸酶。未來將針對此假說做深入之研究,並將進一步探討此磷酸化修飾對HBV生活史中各複製過程之影響。 | zh_TW |
dc.description.abstract | The nucleocapsid protein of Hepatitis B virus (HBV), namely HBc, contains 183 amino acids. The N terminal 1-149 a.a. is sufficient for the viral assembly; and the 150-183 a.a. at C terminal domain (CTD) is responsible for nucleic acid binding activity . It has long been documented that HBc is a phospho-protein, with the major phosphorylation sites at the serine residues within CTD. Aided by the site directed mutagenesis, previous studies demonstrated that the phosphorylation at serine residues of S155, S162, and S170 could be critical for regulating the viral RNA encapsidation and the reverse transcription in viral life cycle. However, the possible structure changes introduced by the site directed mutagenesis make these findings inconclusive. Besides, the putative kinases responsible for the phosphorylation of these serine residues are still remained to be identified.
We propose to address this critical issue by synthesizing the Abs which can recognize the phosphorylated form of specific Ser at CTD of HBc. Four Abs were generated using the synthetic peptides containing phosphorylated Ser residues. The results from dot-blot analysis revealed that P4-4 Ab could recognize the de-phosphorylated form of S162 of HBc. To further validate this, we transfected the wild type and also the HBc mutant constructs, containing specific mutations at each Ser residues of S155, S162, and S170, into Huh-7 cells for the Western blot analysis. The results showed that P4-P Ab has higher affinity for the CIP-treated HBc protein. Moreover, not only showing higher affinity for S162A, the P4-P also showed the higher affinity for S170A. It thus raised a possiblity for the presence of a phosphorylation dependent conformation at the CTD of HBc. P4-P Ab can recognize this conformation when it tends to be de-phosphorylated at S162 and S170. The RNA encapsidation was previously found defective in HBV replcion with S162A and S170A mutations. Therefore, the conformation of HBc recognized by P4-P Ab could be in a “closed form”, which block the accessibility of the arginine rich motif within CTD for interacting with the viral RNA. By treating the HBc protein expressing cells with a panel of kinase inhibitors, PKA was identified as a putative kinase involved in regulating the conformation recognized by P4-P Ab. Two serine residues at CTD of HBc as the PKA consensus sequence, S168 and S176, were mutated to alanine and aspartic acid for evaluating the recognition by P4-P Ab. In comparison with WT, the S168A significantly decreased the signal recognized by P4-P Ab, suggesting that PKA could through this residue to regulate the conformation at HBc CTD. Our current study proposed an interesting possibility for the presence of a phosphorylation dependent structure at the CTD of HBc, which could potentially involved in regulating the viral RNA encapsidation process. Such a possibility and also the effect of PKA mediated regulation of this structure in viral life cycle is worthy to be further investigated. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T17:46:51Z (GMT). No. of bitstreams: 1 ntu-101-R99445115-1.pdf: 2316259 bytes, checksum: 066fbd1b7bb26c18e722b610eb4d9ba3 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 致謝 1
摘要 2 Abstract 4 序論 9 I. HBV所引起的肝臟疾病以及目前治療方式 9 II. HBV的基因結構及生活史 9 III. HBV的核殼蛋白之結構及功能 10 IV. HBV核殼蛋白之磷酸化修飾對功能之影響 11 V. 可能參與核殼蛋白C端磷酸化修飾的磷酸酶 13 VI、本論文研究之目的 14 實驗材料與方法 16 材料 16 方法 17 實驗結果 24 I、製備辨認B型肝炎病毒core protein的C端特定位點磷酸化修飾之抗體 24 II、利用點突變HBc protein質體分析P4-P Ab所辨認的HBc之磷酸化修飾位點 26 III、藉由磷酸化所引起HBc protein CTD結構改變之假說 27 IV、 尋找調控HBc protein CTD結構改變之作用磷酸酶 28 討論 31 參考文獻 35 圖表 40 圖一、利用dot-blot分析P1-P~P4-P抗體對不同peptides (NP及P)之辨認性。 40 圖二、P4-P Ab可能辨認deP-S162位點 (去磷酸化的S162位點)。 41 圖三、P4-P Ab會辨認經CIP reaction(去磷酸化作用)之HBc protein。 42 圖四、利用點突變之mutant HBc protein探討P4-P Ab對S162點突變HBc之辨認力。 43 圖五、利用點突變之mutant HBc探討P4-P Ab對S155,S162,及S170點突變HBc protien之辨認力。 44 圖六、HBc蛋白C端形成特殊結構,影響viral RNA encapsidation之假說示意圖。 45 圖七、藉由kinase inhibitors screening,尋找參與調控HBc蛋白C端形成特殊結構之kinase。 46 圖八、藉由PKA活化劑forscolin之刺激,探討PKA是否參與調控HBc蛋白C端形成特殊結構 (closed form HBc)。 47 圖九、藉由抑制劑H89降低磷酸酶PKA之活性,探討PKA是否參與調控HBc蛋白C端形成特殊結構。 48 圖十、 利用knockdown 細胞中磷酸酶PKA,以探討PKA對調控HBc蛋白C端形成特殊結構之影響。 49 圖十一、利用S168及S176點突變之HBc探討此位點對PKA對HBc蛋白CTD特殊結構之影響。 50 圖十二、〝phosphorylation-induced conformational change〞之假說。 51 | |
dc.language.iso | zh-TW | |
dc.title | 探討B型肝炎病毒核殼蛋白的磷酸化在病毒生活史扮演之角色 | zh_TW |
dc.title | Phosphorylation of Hepatitis B Virus Nucleocapsid Protein in Regulating The Viral Life Cycle | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳培哲,鄧述諄,董馨蓮 | |
dc.subject.keyword | B型肝炎病毒,核殼蛋白,磷酸化,磷酸酶,Serine(S),Alanine(A),Aspartic acid(D), | zh_TW |
dc.subject.keyword | Hepatitis B virus,nucleocapsid,Phosphorylation,Kinase,Serine (S),Alanine(A),Aspartic acid (D), | en |
dc.relation.page | 51 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-08-14 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 2.26 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。